Literature DB >> 3489520

Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression.

M Ono, N Tanaka, K Orita.   

Abstract

We have investigated the effect of partial hepatectomy (HEP) on tumor growth. MH-134 hepatoma cells, which were inoculated in syngeneic C3H/He mice from 3 to 10 days after HEP, grew with a linear increase in size until 7 days, began to regress, and disappeared 14 days after the inoculation. The survival rate was 100%, and the recurrence of tumor was not observed during the following 4 mo. On the other hand, the growth of another syngeneic tumor, X-5563, and of an allogeneic Ehrlich tumor was not affected by HEP. When MH-134 tumor cells were inoculated 7 days before or 15 days after HEP, tumor regression was not observed. The Winn assay showed the presence of tumor-neutralizing activity in spleen cells of MH-134 tumor-regressed mice. Cytotoxic activity against MH-134 tumor cells was also detected in the spleen cells. Analysis by using monoclonal antibodies showed that the effector cells were Thy-1+ and Lyt-2+ cells. Thus, HEP and the following liver cell regeneration may play a role in augmentation of specific immune response to the transplanted hepatoma cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489520

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met.

Authors:  Nadia Harun; Patricia Costa; C Christophi
Journal:  Clin Exp Metastasis       Date:  2013-07-31       Impact factor: 5.150

2.  Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells.

Authors:  Kathrin Rupertus; Otto Kollmar; Claudia Scheuer; Bastian Junker; Michael D Menger; Martin K Schilling
Journal:  Clin Exp Metastasis       Date:  2007-01-27       Impact factor: 5.150

3.  Major liver resection stimulates stromal recruitment and metastasis compared with repeated minor resection.

Authors:  Masashi Momiyama; Takafumi Kumamoto; Atsushi Suetsugu; Hiroyuki Kishimoto; Takashi Chishima; Kuniya Tanaka; Hirotoshi Akiyama; Yasushi Ichikawa; Michael Bouvet; Itaru Endo; Robert M Hoffman
Journal:  J Surg Res       Date:  2012-03-31       Impact factor: 2.192

4.  Minimal liver resection strongly stimulates the growth of human colon cancer in the liver of nude mice.

Authors:  B Rashidi; Z An; F X Sun; A Sasson; R Gamagammi; A R Moossa; R M Hoffman
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

5.  Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Chizuru Matsumoto; Kenichi Matsuo; Kazuhisa Takeda; Yasuhiko Nagano; Shinji Togo
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

6.  Pretreatment with enteral cholestyramine prevents suppression of the cellular immune system after partial hepatectomy.

Authors:  P A Van Leeuwen; M A Boermeester; A P Houdijk; S Meyer; M A Cuesta; R I Wesdorp; M L Rodrick; D W Wilmore
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

7.  Antitumor effects of a new interleukin-2 slow delivery system on methylcholanthrene-induced fibrosarcoma in mice.

Authors:  T Fujiwara; K Sakagami; K Orita
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

8.  Promotion of hepatic metastases by liver resection in the rat.

Authors:  J Mizutani; T Hiraoka; R Yamashita; Y Miyauchi
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

9.  Major hepatic resection may suppress the growth of tumours remaining in the residual liver.

Authors:  H Yokoyama; S Goto; C L Chen; T L Pan; K Kawano; S Kitano
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

10.  Increased growth of colorectal liver metastasis following partial hepatectomy.

Authors:  P Krause; H Flikweert; M Monin; A Seif Amir Hosseini; G Helms; G Cantanhede; B M Ghadimi; S Koenig
Journal:  Clin Exp Metastasis       Date:  2013-02-06       Impact factor: 5.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.